TRAAP2 - TRAnexamic Acid for Preventing postpartum hemorrhage after cesarean delivery: a multicenter randomized, doubleblind, placebo- controlled trial – a study protocol

TRAAP2 - TRAnexamic Acid for Preventing postpartum hemorrhage after cesarean delivery: a multicenter randomized, doubleblind, placebo- controlled trial – a study protocol

Abstract Background An antifibrinolytic agent that blocks lysine-binding sites on plasminogen molecules, tranexamic acid reduces bleeding-related mortality in women with postpartum hemorrhage (PPH), especially administered fairly soon after delivery. According to the randomized controlled trials thu...

Full description

Bibliographic Details
Main Authors: Loïc Sentilhes, Valérie Daniel, Catherine Deneux-Tharaux, On behalf of the TRAAP2 Study Group and the Groupe de Recherche en Obstétrique et Gynécologie (GROG)
Format: Article
Language:English
Published: BMC 2020-01-01
Series:BMC Pregnancy and Childbirth
Subjects:
Postpartum hemorrhage
Treatment
Prevention
Tranexamic acid
Cesarean and vaginal deliveries
Thrombosis
Online Access:https://doi.org/10.1186/s12884-019-2718-4

Internet

https://doi.org/10.1186/s12884-019-2718-4

Similar Items